Overview

Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel in Advanced Ovarian Cancer

Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
Randomized clinical trial to asses the efficacy of closed abdomen hyperthermia intraperitoneal chemotherapy with paclitaxel in ovarian cancer.
Phase:
Phase 3
Details
Lead Sponsor:
PEDRO VILLAREJO CAMPOS
Collaborators:
Hospital General de Ciudad Real
University of Castilla-La Mancha
Treatments:
Albumin-Bound Paclitaxel
Carboplatin
Paclitaxel